The application of Six Sigma to perform quality analyses of plasma proteins
| Autor: | Fumeng Yang, Wenjun Wang, Xizhen Wang, Guangrong Bian, Shijie Teng, Wei Liang, Qian Liu |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Quality Control
030213 general clinical medicine medicine.medical_specialty China Quality management media_common.quotation_subject Clinical Biochemistry Six Sigma General Medicine Blood Proteins 03 medical and health sciences 0302 clinical medicine 030220 oncology & carcinogenesis medicine Humans Medical physics Quality (business) Blood Chemical Analysis media_common Total Quality Management |
| Zdroj: | Annals of clinical biochemistry. 57(2) |
| ISSN: | 1758-1001 |
| Popis: | Background The Six Sigma theory is an important tool for laboratory quality management. It has been widely used in clinical chemistry, haematology and other disciplines. The aim of our study was to evaluate the analytical performance of plasma proteins by application of Sigma metric and to compare the differences among three different allowable total errors in evaluating the analytical performance of plasma proteins. Methods Three different allowable total error values were used as quality goals. Data from an external quality assessment were used as bias, and the cumulative coefficient of variation in internal quality control data was used to represent the amount of imprecision during the same period. Sigma metric of analytes was calculated using the above data. The quality goal index was calculated to provide corrected measures for continuous improvements in analytical quality. Results The Sigma metric was highest using the external quality assessment standards of China: it was sigma ≥6 or higher in 57.1% of plasma proteins. But Sigma metric was lower by using RiliBÄK or biological variation standards. IgG, C3 and C-reactive protein all required quality improvements in imprecision. A single-rule 13s for internal quality control was recommended for IgA, IgM, C4 and rheumatoid factor, whereas multiple rules (13s/22s/R4s) were recommended for IgG, C3 and C-reactive protein, according to the external quality assessment standards of China. Conclusions Different quality goals can lead to different Sigma metric for the same analyte. As the lowest acceptable standard in clinical practice, the external quality assessment standard of China can guide laboratories to formulate reasonable quality improvement programmes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|